EGFR Inhibitors for Lung Cancer Tied to Increased Keratitis Risk

(MedPage Today) -- Patients with lung cancer treated with epidermal growth factor receptor (EGFR) inhibitors may have an increased risk of new-onset keratitis, a U.S. population-based cohort study showed. Over a 20-year period, 1.12% of patients...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news